Showing 5351-5360 of 7750 results for "".
- Castle Biosciences and OHSU Team Up to Fight Melanomahttps://practicaldermatology.com/news/castle-biosciences-and-ohsu-team-up-to-fight-melanoma/2461243/
- ISHRS 2022 Practice Consensus Results: Hair Restoration Trendshttps://practicaldermatology.com/news/ishrs-2022-practice-consensus-results-hair-restoration-trends/2461192/The International Society of Hair Restoration Surgery (ISHRS) released resutls of a new member survey that found 68 percent of members performed an average of one procedure per patient in 2021 to achieve the desired hair restoration result. This represents a significant improvement, as ISHRS memb
- Revelle Aesthetics Rolls Out Avéli to Treat Cellulitehttps://practicaldermatology.com/news/revelle-aesthetics-rolls-out-aveli-to-treat-cellulite/2461189/
- Vaseline Takes on Lack of Diversity in Skin Color Images with New Databasehttps://practicaldermatology.com/news/vaseline-takes-on-lack-of-diversity-in-skin-color-images-with-new-database/2461160/Vaseline is launching See My Skin, a database designed to search for conditions on skin of color and connect patients with dermatologists. Vaseline is introducing See My Skin with HUED, a digital health company focused on improving quality of care for Black, Latinx and Indigen
- RedDress Ships ActiGraft to Ukraine to Treat Civilian Casualtieshttps://practicaldermatology.com/news/reddress-ships-actigraft-to-ukraine-to-treat-civilian-casualties/2461133/
- Study: Use of DermTech’s Melanoma Test Can Cut Costshttps://practicaldermatology.com/news/study-use-of-dermtechs-melanoma-test-can-cut-costs/2461102/New research shows that DermTech’s Pigmented Lesion Assay can reduce costs for commercial health insurance plans when it’s incorporated into the current care pathway of assessing pigmented skin lesions or moles suspicious for melanoma The
- Study: Knowledge of Skin Cancer Risk May Limit Tanning Bed Use, Unhealthy Behaviorshttps://practicaldermatology.com/news/study-knowledge-of-skin-cancer-risk-may-limit-tanning-bed-use-unhealthy-behaviors/2461064/When patients know their risk for skin cancer, they may change their behaviors to lower their chances of developing melanoma, a new study suggests. A recent
- DecisionDx-SCC Performs Well as a Risk-Stratification Tool in Patients with High-risk SCChttps://practicaldermatology.com/news/decisiondx-scc-performs-well-as-a-risk-stratification-tool-in-patients-with-high-risk-scc/2461039/Castle Biosciences, Inc’s DecisionDx-SCC can provide significant and independent prognostic value for stratifying metastasis risk in patients with cutaneous squamous cell carcinoma (SCC) with one or more risk factors (high risk), a new study shows. The study appears in&nb
- Tremfya Five-Year Data Show No New Safety Signalshttps://practicaldermatology.com/news/tremfya-five-year-data-show-no-new-safety-signs/2461016/New data published in the
- Meet Cutera’s truSculpt® flex+https://practicaldermatology.com/news/meet-cuteras-trusculpt-flex/2460999/Cutera is rolling out the next generation of